Crossmark

Engineering pyroptotic vesicles as personalized cancer vaccines

Crossref DOI link: https://doi.org/10.1038/s41565-025-01931-2

Published Online: 2025-05-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Zhaoting https://orcid.org/0000-0002-4596-9603
Wang, Yixin https://orcid.org/0000-0001-9078-4627
Mo, Fanyi https://orcid.org/0009-0001-0530-7621
Wolter, Tyler https://orcid.org/0009-0004-2006-2425
Hong, Rachel https://orcid.org/0009-0001-3142-0281
Barrett, Allie https://orcid.org/0009-0007-1553-2703
Richmond, Nathaniel

Liu, Fengyuan https://orcid.org/0009-0000-4271-865X
Chen, Yu https://orcid.org/0000-0002-9095-6609
Yang, Xicheng https://orcid.org/0009-0001-8390-6507
Dempsey, Lauren https://orcid.org/0009-0007-6258-5015
Hu, Quanyin https://orcid.org/0000-0003-2946-1655
License Information

Text and Data Mining valid from 2025-05-16

Version of Record valid from 2025-05-16
More Information

Article History

Received: 7 July 2024

Accepted: 31 March 2025

First Online: 16 May 2025

Competing interests

: Q.H. and Z.L. have submitted a U.S. patent application related to the findings in this manuscript (U.S. patent application number: 63/708017). The other authors declare no competing interests.